Press Releases November 24, 2025GEMMABio Announces Clinical Trial Authorization for New SMA1 Gene TherapyOctober 7, 2025GEMMABio Launches Rare Therapeutics, Inc. to Develop and Deliver Gene Therapies for Ultra‑Orphan DiseasesJanuary 9, 2025Gene Therapy Pioneer Jim Wilson Comments on iECURE's Announcement of Complete Clinical Response for ECUR-506January 8, 2025Gene Therapy Pioneer Jim Wilson Comments on Solid Biosciences's Announcement of FDA IND Clearance for Friedreich's Ataxia TreatmentGEMMABio Appoints Dr. May Orfali as Chief Medical OfficerDecember 23, 2024GEMMABio Secures $34 Million in Seed Funding to Drive Gene Therapy AdvancementsOctober 8, 2024GEMMABio Announces $100 Million Agreement with Brazil's Leading Health Research InstituteJuly 31, 2024To Further Advance Gene Therapy Research, Industry Pioneer Jim Wilson is Forming Two Independent Companies Dedicated to Genetic Medicine
